79 results
Page 3 of 4
6-K
EX-1.1
6sc25hn
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
dnb0iunb3u
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
u4rptmy
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
353dhxa nar
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
EX-12.1
x2hj6r
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
r5gaiigjd fequ
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
bo1x7x
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
58iixiqqev h5y
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
17hyhea7b1bfotbw8lh6
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
tt08u345
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
gdw j1mww9
10 Jul 19
Prospectus supplement
8:18am
F-3
zfj1h
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
z6pv2ydv2ct
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
w6reb0ibke4d8cct
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
0orme072
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
x276 gillorq
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
lew86x87
27 Mar 19
Securities Purchase Agreement
8:32am